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Abstract
The effect of pyridoxine treatment of a homocystinuric patient on the urinary excretion of
some sulfur-containing amino acids was studied and the following results were obtained. As a
result of pyridoxine treatment, urinary homocystine decreased to a fairly great extent, and its
unusual metabolites S.(3-hydroxy-3-carboxyn- propylthio) homocysteine (HCPTHC) and S-C8-
carboxyethylthio homocysteine (j3-CETHC) increased to some extent. But its oxidation product
(homocysteic acid) showed a tendency to decrease slightly. Urinary methionine and cystine in-
creased to some extent, but cysteinehomocysteine mixed disulfide showed no remarkable change.
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Abstract: The effect of pyridoxine treatment of a homocystinuric
patient on the urinary excretion of some sulfur-containing amino
acids was studied and the following results were obtained. As a
result of pyridoxine treatment, urinary homocystine decreased to a
fairly great extent, and its unusual metabolites S.(3-hydroxy-3-carboxy-
n-propylthio) homocysteine (HCPTHC) and S-C8-carboxyethylthio)
homocysteine (j3-CETHC) increased to some extent. But its oxidation
product (homocysteic acid) showed a tendency to decrease slightly.
Urinary methionine and cystine increased to some extent, but cysteine-
homocysteine mixed disulfide showed no remarkable change.
At least two types of homocystinuria have been recognized: one is
pyridoxine-sensitive and the other fails to respond to pyridoxine treatment,
and most of these investigations are concerned with the changes of methionine,
homocystine and cystine in blood and urine. Recently, however, many un-
usual sulfur-containing amino acids shown in Fig. 1 have been found in the
urine of homocystinuric patient (1-4), so the studies of pyridoxine effect on
the urinary excretion of these unusual metabolites will be of great interest.
Chemical terms and abbreviations of unusual sulfur-containing amino acids
are listed in Fig. 1.
MATERIALS AND METHODS
Pyridoxine hydrochloride (200 mgjdl) was administered daily to a homo-
cystinuric patient found in Osaka for two weeks from October 12 to 26 in 1972,
and four urine samples were collected as follows: 1. Control urine before Be
treatment (6.2liters), August 24-31; 2. Be Administration I in Table 1 (2.6
liters), October 13-19; 3. Be Admimstration II (3.8 liters), October 20-26; 4.
After Be Administration (3.9 liters), November 6-12.
According to our usual method (5), two liters each of urine samples was at
first divided into two fractions by using a column containing one liter of Diaion
SK-l (H form, mesh 1(0), and so-called Fraction I (5) was further divided into
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Fig. I. Unusual Metabolism of Homocysteine in Homocystinuric
Patents.
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1. S-(p'-carboxyethylthio) homocysteine
2. S-(3-hydroxy-3-carboxy-n-propylthio) homocysteine
3. S-I,B-carboxyethyl) homocysteine
4. S-(3-hydroxy-3-carboxy-n-propyl) homocysteine
5. S-(1, 2-dicarboxyethyl) homocysteine
8. S-(,B-carboxyethylthio) cysteine
9. S-(3-hydroxy·3-carboxy-n-propylthio) cysteine
10. S-(carboxymethylthio) homocysteine
II. S-(2-hYdroxY-2-carboxyethYI thio) homocysteine
Abbreviations
,B-CETHC
HCPTHC
$-CEHC
HCPHC
DCEHC
,B-CETC
HCPTC
CMTHC
HCETHC
TABLE I EFFECT OF PYRIDOXINE ADMINISTRATION ON THE EXCRETION OF SULFUR-
CONTAINING AMINO ACIDS IN THE URINE OF A HOMOCYSTINURIC PATIENT
Before B6 Administration AfterI II
Methionine 82.0 129.0 210.0 490.0
Homocystine 260.0 110.0 131. 0 157.0
Mixed disulfide 337.0 233.0 345.8 281.8
Cystine (Half) 49.3 44.0 143.0 89.0
Homocysteic acid 6.72 6.21 4.86 2.20
p-CETHC 0.30 0.95 1. 53 O. 74
HCPTHC 5.17 22.10 15.40 26.50
Values are expressed in f1 moles/liter
three fractions by using a column containing 400 ml of Amberlite IRA-68 (ace-
tate form, mesh 50). Fractions Ib and Ic thus obtained were combined and
transferred to a column containing 500 ml of Diaion SK-l (H form, mesh 1(0).
The effluent and water washings were evaporated to dryness and used for the
determination of homocysteic acid.
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After washing with water, the column was further washed with 2000 ml
of 2 N HCI, 2000 ml of water, and then eluted with 1000 ml of 2 N NH 3 • The
ammonia eluate containing fi-CETHC and HCPTHC was evaporated to dry-
ness and analyzed on an automatic amino acid analyzer (Hitachi Model 034
Liquid Chromatograph). Cystine, methionine, mixed disulfide and homo-
cystine were analyzed directly on an amino acid analyzer after hydrolysis of
each original urine without further fractionation.
RESULTS AND DISCUSSION
Results of pyridoxine effect on the urinary excretion of several sulfur-
containing amino acids are summarized in Table 1.
The excretion of homocystine tends to decrease after pyridoxine treat-
ment and its unusual metabolites CB-CETHC and HCPTHC) increase to some
extent. It is well known that cysteine and also homocysteine react with
pyridoxal to give thiazo1idine derivatives and the latter derivatives cannot
participate directly in pyridoxal-catalyzed reactions (6). So the reduced
excretion of homocystine after Be treatment might be attributed to some
extent to the formation of thiazolidine derivative. But it cannot be denied
that pyridoxine treatment enhances the deamination of homocysteine or homo-
cystine, because of the excretion of its degradation products (p-CETHC and
HCPTHC) being increased.
Decreasing tendency of urinary homocysteic acid may be due to the
reduction of homocysteine in tissues. Even if the amount of mixed disulfide
is taken into account, the amount of urinary homocystine still has a tendency
to decrease and that of cystine to increase. As described above, cysteine also
reacts with pyridoxal to give a thiazolidine derivative. So the increasing
tendency of cystine excretion after Be treatment is inexplicable at present.
Even if the cystathionine synthase remaining in tissues of the patient is con-
sidered to be activated by Be treatment, it is still incomprehensible why
urinary methionine tends to increase after Be treatment. At any rate, such a
patient has not been encountered as yet.
The other sulfur-containing amino acids listed in Table I could not be
measured at this time, because of the repeated fractionations being required
for their determinations as reported in previous papers (1-4).
REFERENCES
1. KODAMA, H., MIZUHARA, S., HARAGUCHI, H. and HIROSAWA, M.: S-(1,2-dicarboxyethyl)
homocysteine in the urine of homocystinuric patients. Physiol. Chern. Phys. 1, 600, 1969
2. KODAMA, H., OHMORJ, S., SUZUKI, M., MIZUHARA, S., OURA, T., ISSHIKI, G. and UEMURA,
I.: Unusual sulfur-containing amino acids in the urine of homocystinuric patients: I.
Physiol. Chern. Phys. 3, 81, 1971
3. KODAMA, H.: Unusual sulfur-containing amino acids in the urine of homocystinuric
3
Kodama et al.: Effect of pyridoxine treatment of a homocystinuric patient on the
Produced by The Berkeley Electronic Press, 1974
246 H. KODAMA, T. IKEGAMI, K. YAO and T. OURA
patients: II. Physiol. Chern. Phys. 3, 159, 1971
4. OHMORI, S., KODAMA, H., IKEGAMI, T., MIZUHARA, S., OURA, T., ISSHIKI, G. and UEMURA,
I.: Unusual sulfur-containing amino acids in the urine of homocystinuric patients: III.
Physiol. Chern. Phys. 4, 286, 1972
5. KODAMA, H., OHMORI, S., SUZUKI, M. and MIZUHARA, S.: New sulfur-containing amino
acids in the urine of cystathioninuric patients: Supplementary data. Physiol. Chern. Phys.
2, 287, 1970
6. ABBOTT, E. H. and MARTELL, A. E.: Pyridoxine and pyridoxal analogs: XIII. ]. Am. chern.
Soc. 92, 1754, 1970
4
Acta Medica Okayama, Vol. 28 [1974], Iss. 4, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol28/iss4/1
